We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.5B
AUM Growth
+$106M
(+1.7%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
52.66%
Holding
925
New
127
Increased
448
Reduced
289
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$56.2M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$44.4M |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$24.2M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$24.1M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$94.9M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$83.7M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$82.4M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$79.7M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.12% |
| 2 | Technology | 8.06% |
| 3 | Healthcare | 5.67% |
| 4 | Energy | 5.37% |
| 5 | Real Estate | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Neurocrine Biosciences
NBIX
$18.4B
| $3.83M | 0.06% |
35,615
-31,629
| -47% | -$3.31M |
|
177
Synchrony
SYF
$25.1B
| $3.81M | 0.06% |
105,922
+5,805
| +6% | +$208K |
|
178
NVR
NVR
$17.3B
| $3.81M | 0.06% |
1,001
+110
| +12% | +$407K |
|
179
Essex Property Trust
ESS
$18.9B
| $3.79M | 0.06% |
12,592
+1,027
| +9% | +$324K |
|
180
Acadia Pharmaceuticals
ACAD
$4.45B
| $3.79M | 0.06% |
88,479
-35,204
| -28% | -$1.53M |
|
181
Ionis Pharmaceuticals
IONS
$9.14B
| $3.77M | 0.06% |
62,437
-35,726
| -36% | -$2.13M |
|
182
Entegris
ENTG
$18B
| $3.76M | 0.06% |
75,030
+9,991
| +15% | +$482K |
|
183
EQT Corp
EQT
$32.3B
| $3.76M | 0.06% |
344,652
-17,711
| -5% | -$173K |
|
184
Illumina
ILMN
$29.2B
| $3.75M | 0.06% |
11,629
+4,296
| +59% | +$1.3M |
|
185
Halliburton
HAL
$26.1B
| $3.75M | 0.06% |
153,280
-52,036
| -25% | -$1.1M |
|
186
Arrowhead Research
ARWR
$12.1B
| $3.74M | 0.06% |
59,029
-157,412
| -73% | -$7.81M |
|
|
NVTA
187
DELISTED
Invitae Corporation
NVTA
| $3.67M | 0.06% |
227,399
-71,587
| -24% | -$1.27M |
|
|
BPMC
188
DELISTED
Blueprint Medicines
BPMC
| $3.65M | 0.06% |
45,525
-36,595
| -45% | -$2.74M |
|
189
KeyCorp
KEY
$24.3B
| $3.64M | 0.06% |
179,873
+9,105
| +5% | +$172K |
|
190
Hartford Financial Services
HIG
$39.3B
| $3.59M | 0.06% |
59,102
+4,673
| +9% | +$280K |
|
|
FRC
191
DELISTED
First Republic Bank
FRC
| $3.59M | 0.06% |
30,583
+1,815
| +6% | +$196K |
|
|
IMMU
192
DELISTED
Immunomedics Inc
IMMU
| $3.59M | 0.06% |
169,469
-134,283
| -44% | -$2.37M |
|
193
Alexandria Real Estate Equities
ARE
$9.41B
| $3.53M | 0.05% |
21,868
+2,114
| +11% | +$333K |
|
|
XYZ
194
Block Inc
XYZ
$49.5B
| $3.53M | 0.05% |
56,379
+5,133
| +10% | +$328K |
|
195
Thermo Fisher Scientific
TMO
$214B
| $3.52M | 0.05% |
10,827
+10,103
| +1,395% | +$3.06M |
|
196
MSCI
MSCI
$42.1B
| $3.51M | 0.05% |
13,596
+1,163
| +9% | +$284K |
|
197
Range Resources
RRC
$8.94B
| $3.5M | 0.05% |
722,665
-333,149
| -32% | -$1.34M |
|
198
Microsoft
MSFT
$2.92T
| $3.49M | 0.05% |
22,150
-1,632
| -7% | -$240K |
|
199
Ameriprise Financial
AMP
$48.3B
| $3.49M | 0.05% |
20,950
+1,189
| +6% | +$184K |
|
200
Murphy Oil
MUR
$5.25B
| $3.48M | 0.05% |
129,909
-81,427
| -39% | -$1.87M |
|
Similar funds
CS
AF
SC
JG
SO
Rafferty Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Rafferty Asset Management held 925 positions worth $6.5B, up 1.7% from $6.39B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Rafferty Asset Management withdrew a net $484M in Q4 2019, closing 61 positions and reducing 289 holdings. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $83.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in Moderna worth $3.18M.
- Rafferty Asset Management's largest Q4 2019 buy was Moderna: 162,744 shares worth $3.18M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $56.2M increase.
- Rafferty Asset Management's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.9M.
- Rafferty Asset Management fully exited State Street Health Care Select Sector SPDR ETF in Q4 2019, selling an estimated $83.7M.
- Rafferty Asset Management's ten largest holdings make up 53% of its $6.5B portfolio in Q4 2019.
- Rafferty Asset Management opened 127 new positions and closed 61 in Q4 2019.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $6.5B.
Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.